INTERNATIONAL PATENT: NIKANG THERAPEUTICS, INC., SHANGHAI BLUERAY BIOPHARMA CO., LTD. FILES APPLICATION FOR "BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS-12D VIA UBIQUITIN PROTEASOME PATHWAY"

GENEVA, Jan. 17 -- NIKANG THERAPEUTICS, INC. (Building E500, 200 Powder Mill RoadWilmington, Delaware 19803), SHANGHAI BLUERAY BIOPHARMA CO., LTD. (Building 3, No. 576 Libing RdPudong New Area, Shanghai 201203) filed a patent application (PCT/CN2024/104753) for "BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS-12D VIA UBIQUITIN PROTEASOME PATHWAY" on Jul 10, 2024. With publication no. WO/2026/011344, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Yongfeng (Building 3, No. 576 Libing RdPudong New Area, Shanghai 201203), ZEN...